Drug Profile
Histamine/serotonin - Beech Tree Labs
Alternative Names: BTL-hs; MD-1; UISH-001Latest Information Update: 03 Nov 2022
Price :
$50
*
At a glance
- Originator Beech Tree Labs
- Class Antidiuretics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Muscular dystrophies
- No development reported Urinary incontinence
Most Recent Events
- 19 Oct 2022 Preclinical trials in Muscular dystrophies in USA (unspecified route) (Beech Tree Labs pipeline; October 2022)
- 19 Oct 2022 Pharmacodynamics data from a preclinical studies in Muscular-dystrophies released by Beech Tree Labs
- 28 Oct 2019 No recent reports of development identified for preclinical development in Muscular-dystrophies in USA